Clinical Trials Logo

Clinical Trial Summary

Autoimmune gastrointestinal dysmotility syndromes are poorly understood, and often difficult to treat because the underlying pathogenesis is unclear. Refractory symptoms result in an impaired quality of life. The presence of positive serum autoantibodies to peripheral nervous system gangliosides and glycoproteins is suggestive of a possible mechanism. Immunomodulator treatments have shown benefit in case reports and case series but standardized data for treatment response is lacking. Therefore, our primary aims are to further characterize this syndrome in terms of symptoms, laboratory testing, pathology, and assess treatment response of immunomodulator therapy. Our research plan involves identifying this subset of patients with autoimmune gastrointestinal dysmotility and dysautonomia, and studying them as they are managed by their gastroenterologists.The study team will administer symptom-based questionnaires in a systematic manner to assess the clinical trajectory of this population and treatment response. The investigators will also analyze laboratory values (antibody titers, tilt testing, inflammatory markers) and study pathology specimens (enteric and skin biopsies) obtained from this cohort to gain a deeper understanding of the pathogenesis of their disease.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04859829
Study type Observational [Patient Registry]
Source Johns Hopkins University
Contact Pankaj J Pasricha, MD
Phone 410-550-1793
Email [email protected]
Status Recruiting
Phase
Start date April 22, 2021
Completion date January 30, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT02421276 - Depressed AIRE Gene Expression Causes Immune Cell Dysfunction & Autoimmunity in Down Syndrome N/A
Recruiting NCT03370861 - How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes
Recruiting NCT02715323 - Exploring Immune Cell Signatures in Autoimmunity and Dry Eye Syndrome
Completed NCT02261688 - Salt and TH-17 in Healthy Human Subjects N/A
Not yet recruiting NCT04791150 - Rheumatologic Adverse Events and Cancer Immunotherapy N/A
Completed NCT03767712 - Trauma as a Trigger for Autoimmunity
Recruiting NCT03206099 - NIAID Centralized Sequencing Protocol
Completed NCT00649246 - Prospective Assessment in Newborns for Diabetes Autoimmunity
Recruiting NCT04521790 - Role of Endomyocardial Biopsy and Aetiology-based Treatment in Patients With Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management
Terminated NCT01129232 - Diabetes Virus Detection Project, Intervention With GAD-alum Phase 2
Recruiting NCT04119713 - Autoimmunity After Checkpoint Blockade
Not yet recruiting NCT02912442 - Thyroid Autoimmunity and Reproductive Failure in Danish Women N/A